NeuRizer Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Selling, General & Admin	2.51	1.32	8.62	8.29	4.42	3.9
Other Operating Expenses	1.08	1.44	3.33	3.91	2.16	2.5
Operating Expenses	3.64	2.8	13.58	12.45	8.86	7.03
Operating Income	-3.64	-2.8	-13.58	-12.45	-8.86	-7.03
Interest Expense	-1.49	-0.15	-0.01	-0	-0.01	-0.15
Interest & Investment Income	0.02	0.02	0.01	0	0	0.03
Other Non Operating Income (Expenses)	-2.94	-2.87	-3.66	-7.95	-4.71	-
EBT Excluding Unusual Items	-8.05	-5.79	-17.25	-20.4	-13.57	-7.15
Gain (Loss) on Sale of Assets	0.19	0.19	0.98	-	-	-
Pretax Income	-7.87	-5.6	-16.26	-20.4	-13.57	-7.15
Net Income	-7.87	-5.6	-16.26	-20.4	-13.57	-7.15
Net Income to Common	-7.87	-5.6	-16.26	-20.4	-13.57	-7.15
Shares Outstanding (Basic)	1,921	1,427	1,032	824	658	567
Shares Outstanding (Diluted)	1,921	1,427	1,032	824	658	567
Shares Change (YoY)	62.68%	38.23%	25.31%	25.14%	16.03%	30.95%
EPS (Basic)	-0.00	-0.00	-0.02	-0.02	-0.02	-0.01
EPS (Diluted)	-0.00	-0.00	-0.02	-0.02	-0.02	-0.01
Free Cash Flow	-4.19	-6.09	-34.32	-16.47	-8.27	-8.76
Free Cash Flow Per Share	-0.00	-0.00	-0.03	-0.02	-0.01	-0.01
EBITDA	-3.6	-2.77	-13.54	-12.29	-8.68	-6.97
D&A For EBITDA	0.04	0.02	0.05	0.16	0.18	0.06
EBIT	-3.64	-2.8	-13.58	-12.45	-8.86	-7.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.